Role of ErbB1 in the Underlying Mechanism of Lapatinib-Induced Diarrhoea: A Review

Lapatinib, an orally administered small-molecule tyrosine kinase inhibitor (SM-TKI), is an effective treatment for ErbB2-positive breast cancer. However, its efficacy as one of the targeted cancer therapies has been hampered by several adverse effects, especially gastrointestinal toxicity, commonly...

Descripción completa

Detalles Bibliográficos
Autores principales: Raja Sharin, Raja Nur Firzanah Syaza, Khan, Jesmine, Ibahim, Mohamad Johari, Muhamad, Mudiana, Bowen, Joanne, Wan Mohamad Zain, Wan Nor I'zzah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256418/
https://www.ncbi.nlm.nih.gov/pubmed/35800225
http://dx.doi.org/10.1155/2022/4165808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256418/
https://www.ncbi.nlm.nih.gov/pubmed/35800225
http://dx.doi.org/10.1155/2022/4165808

Ejemplares similares